{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:15:59Z","timestamp":1784546159834,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.cll.2021.04.002","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T22:11:25Z","timestamp":1626991885000},"page":"541-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Infant Acute Leukemia"],"prefix":"10.1016","volume":"41","author":[{"given":"Gerald","family":"Wertheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cll.2021.04.002_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2018-04-785980","article-title":"How I treat infant leukemia","volume":"133","author":"Brown","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2021.04.002_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmedgenet-2014-102611","article-title":"Juvenile myelomonocytic leukaemia and Noonan syndrome","volume":"51","author":"Strullu","year":"2014","journal-title":"J\u00a0Med Genet"},{"issue":"9","key":"10.1016\/j.cll.2021.04.002_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.23266","article-title":"Lineage switch in childhood acute leukemia: an unusual event with poor outcome","volume":"87","author":"Rossi","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cll.2021.04.002_bib5","series-title":"SEER cancer statistics review, 1975-2017","author":"Howlander","year":"2020"},{"issue":"S7","key":"10.1016\/j.cll.2021.04.002_bib6","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/pbc.21352","article-title":"Acute lymphoblastic leukemia in infancy","volume":"49","author":"Silverman","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"9583","key":"10.1016\/j.cll.2021.04.002_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A\u00a0treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2021.04.002_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fped.2015.00037","article-title":"Acute myeloid leukemia in infants: biology and treatment","volume":"3","author":"Masetti","year":"2015","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.cll.2021.04.002_bib9","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1182\/blood-2002-12-3817","article-title":"Leukemia in twins: lessons in natural history","volume":"102","author":"Greaves","year":"2003","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.cll.2021.04.002_bib10","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","article-title":"Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood\u2009spots","volume":"94","author":"Gale","year":"1997","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"9","key":"10.1016\/j.cll.2021.04.002_bib11","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.070061297","article-title":"Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia","volume":"97","author":"Strick","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.cll.2021.04.002_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1158\/1055-9965.EPI-04-0602","article-title":"Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the Children\u2019s Oncology group","volume":"14","author":"Spector","year":"2005","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"4","key":"10.1016\/j.cll.2021.04.002_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.cll.2021.04.002_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.cll.2021.04.002_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3324\/haematol.2012.067983","article-title":"Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants","volume":"98","author":"Driessen","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cll.2021.04.002_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2004-06-2498","article-title":"FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression","volume":"105","author":"Brown","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cll.2021.04.002_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias\u2014an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"issue":"1\u20132","key":"10.1016\/j.cll.2021.04.002_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2016.12.011","article-title":"Therapeutic targeting of MLL degradation pathways in MLL-rearranged leukemia","volume":"168","author":"Liang","year":"2017","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.cll.2021.04.002_bib20","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2009-09-243634","article-title":"Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting","volume":"115","author":"Schafer","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cll.2021.04.002_bib21","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1182\/blood-2009-07-233049","article-title":"Gene expression profiling\u2013based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.cll.2021.04.002_bib22","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2021.04.002_bib23","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1128\/MCB.01339-06","article-title":"Rbm15 modulates notch-induced transcriptional activation and affects myeloid dfferentiation\u25bf \u2020","volume":"27","author":"Ma","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.cll.2021.04.002_bib24","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1182\/blood-2008-09-180596","article-title":"Role for MKL1 in megakaryocytic maturation","volume":"113","author":"Cheng","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/sj.leu.2401639","article-title":"Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants\/children and a review of 39 cases: report from a t(1;22) study group","volume":"14","author":"Bernstein","year":"2000","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.cll.2021.04.002_bib26","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2016-01-695551","article-title":"Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study","volume":"127","author":"Rooij","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2021.04.002_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2012.10.007","article-title":"An inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia","volume":"22","author":"Gruber","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.cll.2021.04.002_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2017.02.006","article-title":"ETO2-GLIS2 hijacks transcriptional complexes to drive cellular identity and self-renewal in pediatric acute megakaryoblastic leukemia","volume":"31","author":"Thirant","year":"2017","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.cll.2021.04.002_bib29","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1038\/leu.2016.119","article-title":"A\u00a0recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children\u2019s Oncology Group","volume":"30","author":"Brodersen","year":"2016","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cll.2021.04.002_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cell.2007.02.013","article-title":"The retinoblastoma binding protein RBP2 is an H3K4 demethylase","volume":"128","author":"Klose","year":"2007","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.cll.2021.04.002_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.20308","article-title":"Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene","volume":"45","author":"van Zutven","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.cll.2021.04.002_bib32","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3324\/haematol.2019.236745","article-title":"The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia","volume":"106","author":"Noort","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cll.2021.04.002_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajhg.2015.01.017","article-title":"De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay","volume":"96","author":"Arboleda","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.cll.2021.04.002_bib34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/blood-2016-04-712075","article-title":"Acute myeloid leukemia with erythrophagocytosis indicative of KAT6A rearrangement","volume":"128","author":"Montewis","year":"2016","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cll.2021.04.002_bib35","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2013-02-485524","article-title":"Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-M\u00fcnster AML-study group","volume":"122","author":"Coenen","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.04.002_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/gcc.10044","article-title":"Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an International Workshop\u2020","volume":"33","author":"Block","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/asheducation-2013.1.596","article-title":"Treatment of infant leukemias: challenge and promise","volume":"2013","author":"Brown","year":"2013","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.cll.2021.04.002_bib39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/leu.2011.267","article-title":"Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report","volume":"26","author":"Creutzig","year":"2012","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.cll.2021.04.002_bib40","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.cll.2021.04.002_bib41","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.3324\/haematol.2014.106526","article-title":"Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002\/01 protocol have an outcome comparable to that of older children","volume":"99","author":"Masetti","year":"2014","journal-title":"Haematologica"},{"issue":"24","key":"10.1016\/j.cll.2021.04.002_bib42","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2013-07-515148","article-title":"GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia","volume":"122","author":"Roberts","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2021.04.002_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11899-016-0338-x","article-title":"Transient abnormal myelopoiesis and AML in Down syndrome: an update","volume":"11","author":"Bhatnagar","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"26","key":"10.1016\/j.cll.2021.04.002_bib44","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1182\/blood-2011-04-350017","article-title":"Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children\u2019s Oncology Group Study A2971","volume":"118","author":"Gamis","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2021.04.002_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng955","article-title":"Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome","volume":"32","author":"Wechsler","year":"2002","journal-title":"Nat Genet"},{"issue":"22","key":"10.1016\/j.cll.2021.04.002_bib46","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1182\/blood-2010-05-282426","article-title":"Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia","volume":"116","author":"Kanezaki","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2021.04.002_bib47","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1182\/blood-2004-04-1563","article-title":"Prenatal origin of GATA1 mutations may be an initiating step in the development of megakaryocytic leukemia in Down syndrome","volume":"104","author":"Taub","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cll.2021.04.002_bib48","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1182\/blood-2008-04-152967","article-title":"Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations","volume":"112","author":"Tunstall-Pedoe","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2021.04.002_bib49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrc2348","article-title":"GATA1-related leukaemias","volume":"8","author":"Shimizu","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.cll.2021.04.002_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/ng.2759","article-title":"The landscape of somatic mutations in Down syndrome\u2013related myeloid disorders","volume":"45","author":"Yoshida","year":"2013","journal-title":"Nat Genet"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271221000202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:58:59Z","timestamp":1759449539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271221000202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0272271221000202"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2021.04.002","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infant Acute Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2021.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}